Loading...
XKRX
001060
Market cap453mUSD
Oct 08, Last price  
26,350.00KRW
1D
-4.70%
1Q
5.40%
Jan 2017
-50.00%
Name

JW Pharmaceutical Corp

Chart & performance

D1W1MN
XKRX:001060 chart
P/E
9.86
P/S
0.79
EPS
2,671.24
Div yield, %
—
Shrs. gr., 5y
0.78%
Rev. gr., 5y
7.20%
Revenues
774.80b
+7.70%
385,010,282,000437,648,380,000455,146,860,000443,275,672,000431,007,281,000397,084,758,770394,182,301,740412,791,234,930434,352,380,160467,465,120,990502,918,586,610537,181,974,040511,335,343,000547,335,708,000606,584,945,000684,351,099,000748,526,708,000719,375,756,000774,800,812,000
Net income
61.69b
-5.15%
8,761,048,0006,433,178,00010,918,718,0005,600,272,000-9,803,596,000-20,393,601,0002,274,880,2701,446,877,4801,961,427,000-10,933,544,000-742,474,3808,056,888,860-25,275,016,000-15,275,470,000-919,176,00031,891,679,00037,006,334,00065,040,121,00061,688,754,000
CFO
96.40b
+21.42%
14,818,649,000-1,347,997,000-11,118,758,000-11,679,166,000-18,183,738,20064,214,781,68018,724,504,4407,279,097,730-4,174,929,9206,738,635,67033,450,172,29052,109,932,81055,531,085,00063,054,367,00018,123,982,00056,764,439,00087,157,236,00079,391,872,00096,396,463,000
Dividend
Mar 31, 2026650 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Headquartered in Seoul, South Korea, JW Pharmaceutical Corporation is a long-standing entity, established in 1945, specializing in the research, production, and global distribution of a comprehensive range of pharmaceuticals and medical supplies. The company's diverse product portfolio serves markets in Japan and numerous other international regions, addressing a broad spectrum of therapeutic areas including cardiovascular health, gastrointestinal and urinary conditions, central nervous system disorders, infectious diseases, women's health, kidney ailments, respiratory issues, oncology, pain management, and critical care nutrition.

Key people

Yeong Seop Shin
Co-Chief Executive Officer, Director · since 2025
Seong Gwon Han
Vice Chairman · since 2024
Du Yeon Cho
Assistant Managing Director · since 2023
Ja Eok Gu
Assistant Managing Director · since 2023
Yun Ju Jung
Assistant Managing Director · since 2023
Gyeong Eun Kim
Assistant Managing Director
Sang Yil Lee
Assistant Managing Director · since 2023
Gyeong Taek Lee
Assistant Managing Director · since 2023
Gil Chun Yang
Head of Factory · since 2023
Eun Gyeong Hahm
President, Director · since 2025
Jin Suk Kim
Director
Gyeong Ha Lee
Chairman · since 2018
Chan Hui Park
Chief Technology Officer, Director · since 2024
Bo Suk Ahn
Non-Executive Independent Director · since 2025
Jeong Hwan Han
Non-Executive Independent Director
Bi Ho Jeon
Non-Executive Independent Director
Gyu Eon Jung
Non-Executive Independent Director
Wu Tak Lee
Non-Executive Independent Director · since 2025
URL
https://www.jw-pharma.co.kr/
IPO date
Jun 14, 1976
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT